Vimarsana
Biggest News Aggregation in the World

Page 11 - Outcomes Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Outcomes Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Outcomes Data Today - Breaking & Trending Today

PreludeDx™ Presents New Data at the 40th Annual Miami Breast Cancer Conference Identifying Which Patients with DCIS May Be Undertreated Based on Clinicopathologic Factors Alone - Vimarsana News

PreludeDx™ Presents New Data at the 40th Annual Miami Breast Cancer Conference Identifying Which Patients with DCIS May Be Undertreated Based on Clinicopathologic Factors Alone

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it...

Pricey Inclisiran Is Rolling Out: a 'Buy-and-Bill' Model May Smooth Its Path - Vimarsana News

Pricey Inclisiran Is Rolling Out: a 'Buy-and-Bill' Model May Smooth Its Path

At $6,500 per year, without outcomes data, inclirisan faces hurdles. Doctors still expect it to be “transformative.”

Source: tctmd.com